Resmed (RSMDF) Non Operating Investment Income (2020 - 2026)

Resmed (RSMDF) has reported Non Operating Investment Income for 7 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Investment Income rose 139.46% year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2026 stood at -$15.0 million (down 45.77% YoY), and the FY2026 full-year result was -$15.0 million, down 45.78% from the prior year.
• Non Operating Investment Income advanced to $1.0 million in Q2 2026 per RSMDF's latest filing, from -$10.1 million in the prior quarter.
• Across five years, Non Operating Investment Income topped out at $13.9 million in Q1 2024 and bottomed at -$15.5 million in Q2 2024.
• Historically, Non Operating Investment Income has averaged -$1.8 million across 5 years, with a median of -$1.7 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Non Operating Investment Income surged 469.91% in 2023, then sank 876.89% in 2024.
• Over 5 years, Non Operating Investment Income stood at $8.4 million in 2022, then slumped by 122.56% to -$1.9 million in 2023, then advanced by 23.78% to -$1.4 million in 2024, then soared by 121.26% to $306000.0 in 2025, then jumped by 226.8% to $1.0 million in 2026.
• According to Business Quant data, Non Operating Investment Income over the past three periods registered $1.0 million, -$10.1 million, and $306000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.